An agency of the European Union

Signal detection: case studyCardiac valve disease - biphosphonates

Seminaire Signla detection Paris V

2

3

4

5

6

7

8

Stimulated reporting?

9

Women younger than 65 yo?

10

Bias due to the underlying disease?

11

12

Bias linked to the indication for use?

13

Site of the heart valve calcification?

Presentation title (to edit, click View > Header and Footer)14